Importing pharmaceutical products into India is one of the most regulated import categories. Beyond standard customs duty on the bill of entry, pharma importers must navigate CDSCO drug import licenses, temperature-controlled logistics, and complex HS classification across bulk drugs, formulations, and medical intermediates.

Key Regulatory Bodies for Pharma Imports

BodyRoleDocument Required
CDSCO (Central Drugs Standard Control Organisation)Drug import license and No Objection CertificateCDSCO Import License (Form 10 / 41)
State Drug ControllerSome drugs need state-level approvalState NOC or joint authorization
CBIC CustomsHS classification, duty, IGST on BoEStandard bill of entry on ICEGATE
Airport Health Officer (for biologics)Health certificate verificationCertificate from exporting country

HS Code Classification — Pharmaceuticals

Product TypeHS ChapterKey CodesBCD Rate
Bulk drugs (APIs)Chapter 292941 (antibiotics), 2936 (vitamins)0–10%
Formulated medicines (tablets, injections)Chapter 303004 (medicaments in dosage form)0–10%
Vaccines (human use)Chapter 303002.200%
Diagnostic reagentsChapter 3838220–7.5%
Surgical suturesChapter 303006.100%

Pharma Duty Structure (India)

Most life-saving and essential drugs benefit from concessional duty under CBIC notifications:

  • Life-saving drugs (Schedule X, NLEM list): BCD = 0–5%; IGST = 5%
  • Bulk drugs not manufactured in India: BCD = 0% (Notification 12/2012-Customs as amended)
  • Other formulations: BCD = 10%; IGST = 12% or 5%
  • Medical devices (under Chapter 90): Separate rate — see medical devices section

Cold Chain Requirements on the Bill of Entry

For biologics, vaccines, and temperature-sensitive drugs:

  • Bill of entry must note "cold chain commodity" for priority examination
  • Temperature logger records from origin to port of entry must be attached
  • Pharma-grade cold storage at airports: IGI Delhi, CSIA Mumbai have dedicated pharma terminals
  • Customs officer may insist on temperature check before release if chain is broken

CDSCO Import License — What It Covers

The CDSCO Import License (Form 10 or Form 41 for cosmetics) must be obtained before the first shipment. For recurring imports:

  • License is product/drug-specific — one license per drug name
  • Annual renewal required
  • License number must appear on the bill of entry and on all customs documents
  • New drugs (not previously approved in India) require additional approvals

Checklist for Pharma Bill of Entry

  • Commercial invoice with drug name, batch number, quantity, expiry date
  • CDSCO Import License number on BoE
  • Certificate of Analysis (CoA) from manufacturer
  • Good Manufacturing Practice (GMP) certificate of supplier
  • Temperature monitoring records (cold chain)
  • Country of origin certificate
  • Health certificate from exporting country authority (for biologics)

Free template download

Open HTML or Word in any editor. For PDF, use Print → Save as PDF in your browser. Import CSV into Excel or Google Sheets.

Prepare your import documentation

Use free templates, country guides, and step-by-step customs topics — no account required.

Frequently asked questions

A CDSCO Import License (Form 10 for drugs, Form 41 for cosmetics) issued by the Central Drugs Standard Control Organisation. The license number must appear on the bill of entry.

Life-saving drugs: BCD 0–5% + IGST 5%. Other formulations: BCD 10% + IGST 12% or 5%. Many bulk APIs not manufactured in India have BCD 0% under CBIC notifications.

Yes — vaccines, biologics, and temperature-sensitive drugs should be flagged as cold chain commodities on the BoE. Temperature logger records must be submitted with customs documents.